JPMorgan Chase & Co’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Buy |
+61,892
| New | +$136K | ﹤0.01% | 4659 |
|
|
2024
Q4 | – | Sell |
-5,789
| Closed | -$7.24K | – | 6514 |
|
|
2024
Q3 | $7.24K | Buy |
+5,789
| New | +$7.24K | ﹤0.01% | 5371 |
|
|
2024
Q2 | – | Sell |
-6,092
| Closed | -$6.15K | – | 6536 |
|
|
2024
Q1 | $6.15K | Sell |
6,092
-3,701
| -38% | -$3.74K | ﹤0.01% | 5403 |
|
|
2023
Q4 | $10.4K | Buy |
9,793
+5,759
| +143% | +$6.1K | ﹤0.01% | 5372 |
|
|
2023
Q3 | $6.62K | Buy |
4,034
+2,034
| +102% | +$3.34K | ﹤0.01% | 5386 |
|
|
2023
Q2 | $3.14K | Buy |
+2,000
| New | +$3.14K | ﹤0.01% | 5367 |
|
|
2022
Q4 | – | Sell |
-3,550
| Closed | -$7K | – | 5895 |
|
|
2022
Q3 | $7K | Hold |
3,550
| – | – | ﹤0.01% | 5140 |
|
|
2022
Q2 | $8K | Buy |
+3,550
| New | +$8K | ﹤0.01% | 5221 |
|
|
2021
Q3 | – | Sell |
-876
| Closed | -$10K | – | 5721 |
|
|
2021
Q2 | $10K | Buy |
+876
| New | +$10K | ﹤0.01% | 5215 |
|
|
2017
Q2 | – | Sell |
-14
| Closed | -$13K | – | 4492 |
|
|
2017
Q1 | $13K | Buy |
14
+4
| +40% | +$3.71K | ﹤0.01% | 4167 |
|
|
2016
Q4 | $29K | Buy |
+10
| New | +$29K | ﹤0.01% | 4108 |
|